Xenograft models
[18F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F]FDG in human xenograft models
11
Establishment of patient derived non small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
11
Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer
10
Patient derived xenograft models of breast cancer and their predictive power
13
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
13
Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation
15
CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
9
Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models
12
Patient derived xenograft models in musculoskeletal malignancies
16
Establishment and evaluation of four different types of patient-derived xenograft models
11
Leptin produced by obesity altered adipose stem cells promotes metastasis but not tumorigenesis of triple negative breast cancer in orthotopic xenograft and patient derived xenograft models
14
Establishment of patient derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract
14
Patient-derived xenograft models of colorectal cancer in pre- clinical research: a systematic review
14
Analysis of the anti tumor effect of cetuximab using protein kinetics and mouse xenograft models
8
Current status and perspectives of patient-derived xenograft models in cancer research
14
Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models
13
Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
12
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
12
Tumor xenograft animal models for esophageal squamous cell carcinoma
8
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV 1h68
15